Nutrient regulation of tumor and vascular endothelial cell proliferation

Current Cancer Drug Targets

Volumn 7, Issue 5, 2007, Pages 432-437

  Enciso, J M ^a,b   Hirschi, K K ^a,b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b CENTER FOR CELL AND GENE THERAPY   (United States)

Author keywords

Anti angiogenic; Cancer prevention; Cell cycle; Cell proliferation; Cyclin dependent kinase; Cyclin dependent kinase inhibitor; Cyclins; Tumor cells; Vascular endothelial cells; Vitamin A; Vitamin D

Indexed keywords

CELL NUCLEUS RECEPTOR; RETINOIC ACID; RETINOID; RETINOL; VITAMIN D;

ANTIANGIOGENIC ACTIVITY; ANTINEOPLASTIC ACTIVITY; BIOLOGICAL ACTIVITY; CANCER; CANCER PREVENTION; CELL CYCLE REGULATION; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL TRANSFORMATION; CELL TYPE; CELL VIABILITY; DRUG MECHANISM; FOOD COMPOSITION; HUMAN; INHIBITION KINETICS; METASTASIS; NONHUMAN; NUTRIGENOMICS; REVIEW; SOLID TUMOR; TUMOR GROWTH; VASCULAR ENDOTHELIUM;

ANIMALS; CELL PROLIFERATION; ENDOTHELIAL CELLS; FOOD; HUMANS; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC;

EID: 34547610435     PISSN: 15680096     EISSN: None     Source Type: Journal    
DOI: 10.2174/156800907781386597     Document Type: Review

References (82)

1. Bohnsack, B. L.; Hirschi, K. K. Nutrient Regulation of Cell Cycle Progression. Annu. Rev. Nutr. 2004, 24, 433-453.
2. Folkman, J. Tumor Angiogenesis: Therapeutic Implications. N. Engl. J. Med. 1971, 285, 1182-1186.
3. Zhong, H.; Bowen, J. P. Antiangiogenesis Drug Design: Multiple Pathways Targeting Tumor Vasculature. Curr. Med. Chem. 2006, 13, 849-862.
4. Carmeliet, P.; Jain, R. K. Angiogenesis in Cancer and Other Diseases. Nature 2000, 407, 259-257.
5. McDonald, D. M.; Foss, A. J. Endothelial Cells of Tumor Vessels: Abnormal But Not Absent. Cancer Metastasis Rev. 2000, 19, 109-120.
6. McDonald, D. M.; Baluk, P. Significance of Blood Vessel Leakiness in Cancer. Cancer Res. 2002, 62, 5381-5385.
7. Morikawa, S.; Baluk, P.; Kaidoh, T.; Haskell, A.; Jain, R. K.; McDonald, D. M. Abnormalities in Pericytes on Blood Vessels and Endothelial Sprouts in Tumors. Am. J. Pathol. 2002, 160, 985-1000.
8. Evans, R. M. The Steroid and Thyroid Hormone Receptor Superfamily. Science 1988, 240, 889-895.
9. Chambon, P. The Retinoid Signaling Pathway: Molecular and Genetic Analyses. Semin. Cell Biol. 1994, 5, 115-125.
10. Mangelsdorf, D. J. Vitamin A Receptors. Nutr. Rev. 1994, 52, S32-44;
11. Evans T. R. J.; Kaye, S. B. Retinoids: Present Role and Future Potential. Br. J. Cancer 1999, 80, 1-8.
12. Evans, T. R. J.; Kaye, S. B. Retinoids: Present Role and Future Potential. Br. J. Cancer 1999, 80, 1-8.
13. Altucci, L.; Gronemeyer, H. The Promise of Retinoids To Fight Against Cancer. Nat. Rev. Cancer 2001, 1, 181-193.
14. Hartwell, L. H.; Kastan, M. B. Cell Cycle Control and Cancer. Science 1994, 266, 1821-1828.
15. Sherr, C. J.; Roberts, J. M. CDK Inhibitors: Positive and Negative Regulation of G1-Phase Progression. Genes Dev. 1999, 13, 1501-1512.
16. Shao, Z. M.; Dawson, M. L.; Li, X. S.; Rishi, A. K.; Sheikh, M. S.; Han, Q. X.; Ordonez, J. V.; Shroot, B.; Fontana, J. A. p53 Independent G0/G1 Arrest and Apoptosis Induced by a Novel Retinoid in Human Breast Cancer Cells. Oncogene 1995, 11, 493-504.
17. Cheung, B.; Hocker, J. E.; Smith, S. A.; Norris, M. D.; Haber, M.; Marshall, G. M. Favorable Prognostic Signficance of High-Level Retinoic Acid Receptor Beta Expression in Neuroblastoma Mediated by Effects on Cell Cycle Regulation. Oncogene 1998, 17, 751-759.
18. Mangiarotti, R.; Danova, M.; Alberici, R.; Pellicciari, C. All-trans Retinoic Acid (ATRA)-Induced Apoptosis is Preceded by G1 Arrest in Human MCF-7 Breast Cancer Cells. Br. J. Cancer 1998, 77, 186-191.
19. Yang, L.; Ostrowski, J.; Reczek, P.; Brown, P. The Retinoic Acid Receptor Antagonist, BMS453, Inhibits Normal Breast Cell Growth By Inducing Active TGF-beta and Causing Cell Cycle Arrest. Oncogene 2001, 20, 8025-8035.
20. Dimberg, A.; Oberg, F. Retinoic Acid-Induced Cell Cycle Arrest of Human Myeloid Cell Lines. Leuk. Lymphoma 2003, 44, 1641-1650.
21. Yu, Z.; Lin, J.; Xiao, Y.; Hen, J.; Zhang, X; Jia, H.; Tang, Y; Li, Y. Induction of Cell-Cycle Arrest by All-trans Retinoid Acid in Mouse Embryonic Palatal Mesenchymal Cell. Toxicol. Sci. 2005, 83, 359-354.
22. Guo, J. M.; Xiao, B. X.; Kang, G. Z.; Liu, D. H.; Chen, H.; Zhang, S.; Zhang, X. N. Int. J. Gynecol. Cancer 2006, 16, 341-346.
23. Weinberg, R. A. The Retinoblastoma Protein and Cell Cycle Control. Cell 1995, 81, 323-330.
24. Nevins, J. R.; Leone, G.; DeGregori, J.; Jakoi, L. Role of the Rb/E2F Pathway in Cell Growth Control. J. Cell Physiol. 1997, 173, 233-236.
25. Sah, J. F.; Eckert, R. L.; Chandraratna, R. A.; Rorke, E. A. Retinoids Suppress Epidermal Growth Factor-Associated Cell Proliferation by Inhibiting Epidermal Growth Factor Receptor-dependent ERK 1/2 Activation. J. Biol. Chem. 2002, 277, 9728-9735.
26. Alisi, A.; Leoni, S.; Piacentani, A.; Conti Devirgiliis, L. Retinoic Acid Modulates the Cell-cycle in Fetal Rat Hepatocytes and HepG2 Cells by Regulating Cyclin-CDK Activities. Liver Int. 2003, 23, 179-186.
27. Zhang, D.; Vuocolo, S.; Masciullo, V.; Sava, T.; Giordano, A.; Soprano, D. R.; Soprano, K. J. Cell Cycle Genes As Targets of Retinoid Induced Ovarian Tumor Cell Growth Suppression. Oncogene 2001, 20, 7935-7944.
28. Vuocolo, S.; Soprano, D. R.; Soprano, K. J. p27/Kip 1 Mediates Retinoic Acid- Induced Suppression of Ovarian Carcinoma Cell Growth. J. Cell. Physiol. 2004, 199, 237-243.
29. Dimberg, A.; Bahram, F.; Karlberg, I.; Larsson, L. G.; Nilsson, K.; Oberg, F. Retinoic Acid-Induced Cell Cycle Arrest of Human Myeloid Cell Lines is Associated With Sequential Down-Regulation of c-Myc and Cyclin E and posttranscriptional up-regulation of p27(Kip1). Blood 2002, 99, 2199-2206.
30. Dimberg, A.; Nilsson, K.; Oberg, F. Phosphorylation-Deficient Stat1 Inhibits Retinoic Acid-Induced Differentiation and Cell Cycle Arrest in U-937 monoblasts. Blood 2000, 96, 2870-2888.
31. Dedieu, S.; Lefebvre, P. Retinoids Interfere with AP1 Signalling Pathway in Human Breast Cancer Cells. Cell. Signal. 2006, 18, 889-898.
32. Elstner, E.; Muller, C.; Koshizuka, K.; Williamson, E. A.; Park, D.; Asou, H.; Shintaku, P; Said, J. W.; Heber, D.; Koeffler, H. P. Ligands for Peroxisome Proliferator-Acitvated Receptor γ and Retinoic Acid Receptor Inhibit Growth and Induce Apoptosis of Human Breast Cancer Cells in vitro and in BNX Mice. Proc. Natl. Acad. Sci. USA 1998, 95, 8806-8811.
33. James, S. Y.; Lin, F.; Kolluri, S. K.; Dawson, M. I.; Zhang, X. K. Regulation of Retinoic Acid Receptor Beta Expression by Peroxisome Proliferator-Activated Receptor Gamma Ligands in Cancer Cells. Cancer Res. 2003, 63, 3531-3538.
34. Houle, B.; Rochette-Egly, C.; Bradley, W. E. C. Tumor-Suppressive Effect of the Retinoic Acid Receptor β in Human Epidermoid Lung Cancer Cells. Proc. Natl. Acad. Sci. USA 1993, 90, 985-989.
35. Oikawa, T.; Hirotani, K.; Nakamura, O.; Shudo K.; Hiragun, A.; Iwaguchi, T. A Highly Potent Antiangiognenic Activity of Retinoids. Cancer Lett. 1989, 48, 157-162.
36. Oikawa, T.; Okayasu, I.; Ashino, H.; Morita, I.; Murota, S.; Shudo, K. Three novel synthetic retinoids, Re 80, Am 580 and Am 80, All Exhibit Anti-Angiogenic Activity in vivo. Eur. J. Pharmacol. 1993, 249, 113-116.
37. Majewski, S.; Szmurlo, A.; Marczak, M.; Jablonska, S.; Bollag, W. Synergistic Effect of Retinoids on Interferon Alpha or Tumor-Induced Angiogenesis: Anti- angiogenic effect on HPV-harboring tumor-cell lines. Int. J. Cancer 1994, 51, 81-85.
38. Majewski, S.; Marczak, M.; Szmurlo, A.; Jablonska, S.; Bollag, W. Retinoids, Interferon Alpha, 1, 24-dihydroxyvitamin D3 and Their Combination Inhibit Angiogenesis Induced by Non-HPV-Harboring Tumor Cell Lines. RAR Alpha Mediates the Antiangiogenic Effect of Retinoids. Cancer Lett. 1995, 89, 117- 124.
39. Lai, L.; Bohnsack, B. L.; Niederreither K.; Hirchi, K. K. Retinoic Acid Regulates Endothelial Cell Proliferation During Vasculogenesis. Development 2003, 130, 6465-6474.
40. Ekholm, S. V.; Reed, S. I. Regulation of G(1) Cyclin-Dependent Kinases in Mammalian Cell Cycle. Curr. Opin. Cell Biol. 2000, 12, 676-684.
41. Pakala, R.; Benedict, C. R. Modulation of Endothelial Cell Proliferation by Retinoid X Receptor Agonists. Eur. J. Pharmacol. 1999, 385, 255-261.
42. Gaetano, C.; Catalano, A.; Illi, B.; Felici, A.; Minucci, S.; Palumbo, R.; Facchiano, F.; Mangoni, A.; Mancarella, S.; Muhlhauser, J.; Capogrossi, M. C. Retinoids Induce Fibroblast Growth Factor-2 Production in Endothlial Cells via Retinoic Acid Receptor Alpha Activation and Stimulate Angiogenesis In vitro and In vivo. Circ. Res. 2001, 88, E38-E47.
43. Bohnsack, B. L.; Lai, L.; Dolle, P.; Hirschi, K. K. Signaling Hierarchy Downstream of Retinoic Acid that Independently Regulates Vascular Remodeling and Endothelial Cell Proliferation. Genes Dev. 2004, 18, 1345-1358.
44. 3 Production by Human Keratinocytes. Kinetics and Regulation. J. Clin. Invest. 1986, 78, 557- 566.
45. Reichel, H.; Koeffler, H. P.; Norman, A. W. Production of 1 alpha, 25-dihydroxyvitamin D3 by Hematopoietic Cells. Prog. Clin. Biol. Res. 1990, 332, 81-97.
46. Townsend, K.; Banwell, C. M.; Guy, M.; Colston, K. W.; Mansi, J. L.; Stewart, P. M.; Campbell, M. J.; Hewison, M. Autocrine Metabolism of Vitamin D in Normal and Malignant Breast Tissue. Clin. Cancer Res. 2005, 11, 3579-3586.
47. Matusiak, D.; Murillo, G.; Carroll, R. E.; Mehta, R. G.; Benya, R. V. Expression of Vitamin D Receptor and 25-Hydroxyvitamin D3-1 {Alpha}-Hydroxylase in Normal and Malignant Human Colon. Cancer Epidemiol. Biomarkers Prev. 2005, 14, 2370-2376.
48. 3 on Primary Cultures of Human Prostatic Cells. Cancer Res. 1994, 54, 805-810.
49. 3. Cancer Epidemiol. Biomarkers Prev. 1998, 7, 391-395.
50. Reichel, H.; Koeffler, H. P.; Norman, A. W. The Role of the Vitamin D Endocrine System in Health and Disease. New. Engl. J. Med. 1989, 320, 980-991.
51. 3 and Clinical Applications. Bone 1995, 17, 107S-111S.
52. Canaff, L.; Hendy, G. N. Human Calcium-Sensing Receptor Gene. Vitamin D Response Elements in Promoters P1 and P2 confer Transcriptional Responsiveness to 1, 25-dihyroxyvitamin D. J. Biol. Chem. 2002, 277, 30337-30350.
53. Saramaki, A.; Banwell, C. M.; Campbell, M. J.; Carlberg, C. Regulation of the Human p21 (Waf1/Cip1) Gene Promoter Via Multiple Binding sites for p53 and the Vitamin D3 Receptor. Nucleic Acids Res. 2006, 34, 543-554.
54. Carlberg, C.; Dunlop, T. W. The Impact of Chromatin Organization of Vitamin D Target Genes. Anticancer Res. 2006, 26, 2637-2645.
55. Norman, A. W. Vitamin D Receptor (VDR): New Assignments for an Already Busy Receptor. Endocrinology 2006, 147(12), 5542-5548.
56. Norman, A. W.; Mizwicki, M. T.; Norman, D. P. G. Steroid-Hormone Rapid Actions, Membrane Receptors and a Conformational Ensemble Model. Nat. Rev. Drug Discov. 2004, 3, 27-41.
57. Garland, C. F.; Garland, F. C. Do Sunlight and Vitamin D Reduce the Likelihood of Colon Cancer? Int. J. Epidemiol. 1980, 9, 227-231.
58. Garland, C. F.; Constock, G. W.; Garland, F. C.; Helsing, K. J.; Shaw, E. K.; Gorham, E. D.; Serum 25-Hydroxyvitamin D and Colon Cancer: Eight-Year Prospective Study. Lancet 1989, 2, 1176-1178.
59. Garland, F. C.; Garland, C. F.; Gorham, E. D.; Young, J. F. Geographic Variation in Breast Cancer Mortality in the United States: A Hypothesis Involving Exposure to Solar Radiation. Prev. Med. 1990, 19, 614-622.
60. Schwartz, G. G.; Hulka, B. S. Is Vitamin D Deficiency a Risk Factor for Prostate Cancer? (Hypothesis). Anticancer Res. 1990, 10, 1307-1311.
61. Scaglione-Sewell, B. A.; Bissonnette, M.; Skarosi, S.; Abraham, C.; Brasitus, T. A. A Vitamin D3 Analog Induces a G1-Phase Arrest in CaCo-2 Cells by Inhibiting Cdk2 and Cdk6: Roles of Cyclin E, p21Waf1, and p27Kip1. Endocrinology 2000, 14, 3931-3939.
62. Arber, N.; Hibshoosh, H.; Moss, S. F.; Sutter, T.; Zhang, Y.; Begg, M.; Wang, S.; Weinstein, I. B.; Holt, P. R. Increased Expression of Cyclin D1 is an Early Event in Multistage Colorectal Carcinogenesis. Gastroenterology 1996, 110, 669-674.
63. Zhang, T.; Nanney, L. B.; Luongo, C.; Lamps, L.; Heppner, K. J.; DuBois, R. N.; Beauchamp, R. D. Concurrent Overexpression of Cyclin D1 and Cyclin- Dependent Kinase 4 (Cdk4) in Intestinal Adenomas from Multiple Intestinal Neoplasia (Min) Mice and Human Familial Adenomatous Polyposis Patients. Cancer Res. 1997, 57, 169-175.
64. Lamprecht, S. A.; Lipkin, M. Chemoprevention of Colon Cancer by Calcium, Vitamin D and Folate: Molecular Mechanisms. Nat. Rev. Cancer 2003, 3, 601-614.
65. Yang, W.; Bancroft, L.; Nicholas, C.; Lozonschi, I.; Augenlicht, L. H. Targeted Inactivation of p27kip1 is Sufficient for Large and Small Intestinal Tumorigenesis in the Mouse, Which Can Be Augmented by a Western-Style High-Risk Diet. Cancer Res. 2003, 63, 4990-4996.
66. 3 in Human Prostate Cancer Cell Line LNCaP Involves Reduction of Cyclin-Dependent Kinase 2 Activity and Persistent G1 Accumulation. Endocrinology 1998, 139, 1197-1207.
67. Polek, T. C.; Weigel, N. L. Vitamin D and Prostate Cancer. J. Androl. 2002, 23, 9-17.
68. Polek, T. C.; Stewart, L. V.; Ryu, E. J.; Cohen, M. B.; Allegretto, E. A.; Weigel, N. L. p53 is Required for 1, 25-Dihydroxyvitamin D3-Induced G0 Arrest But Is Not Required for G1 Accumulation or Apoptosis of LNCaP Prostate Cancer Cells. Endocrinology 2003, 144, 50-60.
69. Verlinden, L.; Verstuyf, A.; Convents, R.; Marcelis, S.; Van Camp, M.; Bouillon, R. Action of 1, 25(OH)2D3 on the Cell Cycle Genes, Cyclin D1, p21 and p27 in MCF-7 Cells. Mol. Cell Endocrinol. 1998, 142, 57-65.
70. Verlinden, L.; Verstuyf, A.; Van Camp, M.; Marcelis, S.; Sabbe, K.; Zhao, X. Y.; De Clercq, P.; Vandewalle, M.; Bouillon, R. Two Novel 14-Epi-Analogues of 1, 25-Dihydroxyvitamin D3 Inhibit the Growth of Human Breast Cancer Cells in vitro and in vivo. Cancer Res. 2000, 60, 2673-2679.
71. Jensen, S. S.; Madsen, M. W.; Lukas, J.; Binderup, L.; Bartek, J. Inhibitory Effects of 1α, 25-Dihydroxyvitamin D, on the G1-S Phase-Controlling Machinery. Mol. Endocrinol. 2001, 15, 1370-1380.
72. Saramaki, A.; Banwell, C. M.; Campbell, M. J.; Carlberg, C. Regulation of the Human p21 (Waf1/Cip1) Gene Promoter via Multiple Binding Sites for p53 and the Vitamin D3 Receptor. Nucleic Acids Res. 2006, 34, 543-554.
73. Carlberg, C.; Dunlop, T. W. The Impact of Chromatin Organization of Vitamin D Target Genes. Anticancer Res. 2006, 26, 2637-2645.
74. Kallay, E.; Bareis, P.; Bajna, E.; Kriwanek, S.; Bonner, E.; Toyokuni, S.; Cross, H. S. Vitamin D Receptor Activity and Prevention of Colonic Hyperproliferation and Oxidative Stress. Food Chem. Toxicol. 2002, 40, 1191-1196.
75. Kallay, E.; Pietschmann, P.; Toyokuni, S.; Bajna, E.; Hahn, P.; Mazzucco, K.; Bieglmayer, C.; Kato, S.; Cross, H. S. Characterization of a Vitamin D Receptor Knockout Mouse as a Model of Colorectal Hyperproliferation and DNA Damage. Carcinogenesis 2001, 22, 1429-1435.
76. Sheinin, Y.; Kaserer, K.; Wrba, F.; Wenzl, E.; Kriwanek, S.; Peterlik, M.; Cross, H. S. In situ mRNA Hybridization Analysis and Immunolocalization of the Vitamin D Receptor in Normal and Carcinomatous Human Colonic Mucosa: Relation to Epidermal Growth Factor Receptor Expression. Virchows Arch. 2000, 437, 501-507.
77. Mills, S. J.; Mathers, J. C.; Chapman, P. D.; Burn, J.; Gunn, A. Colonic Crypt Proliferation State Assessed by Whole Crypt Microdissection in Sporadic Neoplasia and Familial Adenomatous Polyposis. Gut 2001, 48, 41-46.
78. Merke, J.; Milde, P.; Lewicka, S.; Hugel, U.; Klaus, G.; Mangelsdorf, D. J.; Haussler, M. R.; Rauterberg, E. W.; Ritz, E. J. Identification and Regulation of 1, 25-Hydroxyvitamin D3 Receptor Activity and Biosynthesis of 1, 25-Hydroxyvitamin D3: Studies in Cultured Bovine Aortic Endothelial Cells and Human Dermal Capillaries. J. Clin. Invest. 1989, 83, 1903-1915.
79. Mantell, D. J.; Owens, P. E.; Bundred, N. J.; Mawer, E. B.; Canfield, A. E. 1, 25-Hydroxyvitamin D3 Inhibits Angiogenesis In vitro and In vivo. Circ. Res. 2000, 87, 214-220.
80. 3 Analogues. Eur. J. Pharmacol. 1990, 178, 247-250.
81. 3 and Vitamin D Analogs on Tumor-Derived Endothelial Cells. Endocrinology 2002, 143, 2508- 2514.
82. Majewski, S.; Skopinska, M.; Marczak, M.; Szmurlo, A.; Bollag, W.; Jablonska, S. Vitamin D3 is a Potent Inhibitor of Tumor Cell-Induced Angiogenesis. J. Investig. Dermatol. Symp. Proc. 1996, 1, 97-101.